Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Dec 20:5:272.
doi: 10.3389/fped.2017.00272. eCollection 2017.

Is Autosomal Dominant Polycystic Kidney Disease Becoming a Pediatric Disorder?

Stéphanie De Rechter  1   2 , Luc Breysem  3 , Djalila Mekahli  1   2
Affiliations
Review

Is Autosomal Dominant Polycystic Kidney Disease Becoming a Pediatric Disorder?

Stéphanie De Rechter et al. Front Pediatr. .

Abstract

Autosomal dominant polycystic kidney disease (ADPKD) affects 1 in 400 to 1,000 live births, making it the most common monogenic cause of renal failure. Although no definite cure is available yet, it is important to affect disease progression by influencing modifiable factors such as hypertension and proteinuria. Besides this symptomatic management, the only drug currently recommended in Europe for selected adult patients with rapid disease progression, is the vasopressin receptor antagonist tolvaptan. However, the question remains whether these preventive interventions should be initiated before extensive renal damage has occurred. As renal cyst formation and expansion begins early in life, frequently in utero, ADPKD should no longer be considered an adult-onset disease. Moreover, the presence of hypertension and proteinuria in affected children has been reported to correlate well with disease severity. Until now, it is controversial whether children at-risk for ADPKD should be tested for the presence of the disease, and if so, how this should be done. Herein, we review the spectrum of pediatric ADPKD and discuss the pro and contra of testing at-risk children and the challenges and unmet needs in pediatric ADPKD care.

Keywords: autosomal dominant polycystic kidney disease; children; prevention; testing; treatment.

PubMed Disclaimer

References

    1. Gabow PA. Autosomal dominant polycystic kidney disease. N Engl J Med (1993) 329:332–42.10.1056/NEJM199307293290508 - DOI - PubMed
    1. Porath B, Gainullin VG, Cornec-Le Gall E, Dillinger EK, Heyer CM, Hopp K, et al. Mutations in GANAB, encoding the glucosidase IIalpha subunit, cause autosomal-dominant polycystic kidney and liver disease. Am J Hum Genet (2016) 98:1193–207.10.1016/j.ajhg.2016.05.004 - DOI - PMC - PubMed
    1. Reed B, McFann K, Kimberling WJ, Pei Y, Gabow PA, Christopher K, et al. Presence of de novo mutations in autosomal dominant polycystic kidney disease patients without family history. Am J Kidney Dis (2008) 52:1042–50.10.1053/j.ajkd.2008.05.015 - DOI - PMC - PubMed
    1. Iliuta IA, Kalatharan V, Wang K, Cornec-Le Gall E, Conklin J, Pourafkari M, et al. Polycystic kidney disease without an apparent family history. J Am Soc Nephrol (2017) 28:2768–76.10.1681/ASN.2016090938 - DOI - PMC - PubMed
    1. Cornec-Le Gall E, Audrezet MP, Rousseau A, Hourmant M, Renaudineau E, Charasse C, et al. The PROPKD score: a new algorithm to predict renal survival in autosomal dominant polycystic kidney disease. J Am Soc Nephrol (2015) 27:942–51.10.1681/ASN.2015010016 - DOI - PMC - PubMed